脱细胞角膜基质层片移植伴或不伴干细胞再细胞化治疗晚期圆锥角膜
这项1期临床试验初步评估了脱细胞人角膜基质层片移植伴或不伴自体脂肪来源成体干细胞再细胞化,用于晚期圆锥角膜患者角膜基质内的安全性和有效性。5例接受单纯脱细胞层片,4例接受再细胞化层片,随访6个月,所有视觉参数总体改善,但组间无显著差异。结论认为脱细胞人角膜基质层片移植对晚期圆锥角膜似乎安全且中等有效,再细胞化的潜在益处尚不明确。
要点
- 9例晚期圆锥角膜患者接受脱细胞角膜基质层片移植,5例单纯层片,4例再细胞化层片。
- 术后6个月所有视觉参数总体改善,平均未矫正视力从0.109提高到0.232(P = .05)。
- 组间无显著差异,再细胞化的潜在益处尚不明确。
核心结论
- 脱细胞人角膜基质层片移植对晚期圆锥角膜似乎安全且中等有效。
- 用自体脂肪来源成体干细胞进行再细胞化的潜在益处尚不明确。
研究设计与样本
- 1期临床试验,共纳入9例晚期圆锥角膜患者。
- 飞秒激光辅助制作120μm厚度、9mm直径的层片,取自人供体角膜前基质,并用十二烷基硫酸钠溶液脱细胞。
- 自体脂肪来源成体干细胞通过择期吸脂术获取,并培养在层片两侧。
- 5例患者接受单纯脱细胞层片,4例患者接受再细胞化层片,在表面麻醉下植入飞秒激光辅助的9.5mm直径层间囊袋。
- 总随访时间为6个月。
主要发现
- 截至第3个月,无病例出现临床混浊或瘢痕。
- 术后6个月,患者所有视觉参数总体改善,平均未矫正视力从0.109提高到0.232(P = .05),矫正远视力从0.22提高到0.356(P = .068)。
- 所有患者屈光球镜改善(从-4.55D到-2.69D;P = .017),但屈光柱镜保持稳定(从-2.83到-2.61;P = .34)。
- 观察到所有前部角膜曲率值有改善趋势;所有厚度参数平均改善120μm(P = .008),球面像差改善(P = .018),彗差(P = .23)和总高阶像差(P = .31)。
- 组间未检测到显著差异。
关键数值与推荐
- 术后6个月平均未矫正视力从0.109提高到0.232(P = .05)。
- 术后6个月矫正远视力从0.22提高到0.356(P = .068)。
- 屈光球镜从-4.55D改善到-2.69D(P = .017),屈光柱镜从-2.83到-2.61保持稳定(P = .34)。
- 所有厚度参数平均改善120μm(P = .008),球面像差改善(P = .018),彗差(P = .23),总高阶像差(P = .31)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This phase 1 study seeks to preliminarily evaluate the safety and efficacy of decellularized human corneal stromal lamina transplantation with or without autologous adipose-derived adult stem cell recellularization within the corneal stroma of patients with advanced keratoconus. DESIGN: Phase 1 clinical trial. METHODS: Femtosecond-assisted 120-μm thickness and 9-mm diameter laminas were obtained from the anterior stroma of human donor corneas and decellularized with a sodium dodecyl sulfate solution. Autologous adipose-derived adult stem cells were obtained by elective liposuction and cultured onto both sides of the lamina. Five patients received the decellularized lamina alone and 4 patients the recellularized lamina into a femtosecond-assisted 9.5-mm diameter lamellar pocket under topical anesthesia. The total duration of follow-up was 6 months. RESULTS: No case showed clinical haze or scarring by month 3. Six months after surgery, patients showed a general improvement of all visual parameters, with a mean unaided visual acuity from 0.109 to 0.232 (P = .05) and corrected distance visual acuity from 0.22 to 0.356 (P = .068). Refractive sphere improved in all patients (from -4.55 diopters [D] to -2.69 D; P = .017), but refractive cylinder remained stable (from -2.83 to -2.61; P = .34). An improvement tendency of all anterior keratometric values was observed. A mean improvement of 120 μm in all thickness parameters was confirmed (P = .008), as well as an improvement in the spherical aberration (P = .018), coma (P = .23) and total higher order aberrations (P = .31). No significant differences among groups were detected. CONCLUSIONS: Decellularized human corneal stromal laminas transplantation seems safe and moderately effective for advanced keratoconus. Potential benefits of its recellularization with autologous adipose-derived adult stem cells remains unclear.
引用
- Alió Del Barrio JL, El Zarif M, Azaar A, et al. Corneal Stroma Enhancement With Decellularized Stromal Laminas With or Without Stem Cell Recellularization for Advanced Keratoconus. Am J Ophthalmol. 2017. PMID: 29103962. doi:10.1016/j.ajo.2017.10.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。